ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $928,000 | +472.8% | 5,391 | +217.9% | 0.02% | +155.6% |
| Q2 2020 | $162,000 | +1925.0% | 1,696 | +987.2% | 0.01% | – |
| Q4 2019 | $8,000 | +300.0% | 156 | +164.4% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 59 | -3.3% | 0.00% | – |
| Q2 2019 | $3,000 | -97.9% | 61 | -98.0% | 0.00% | -100.0% |
| Q1 2019 | $145,000 | -88.6% | 3,109 | -86.0% | 0.01% | -89.2% |
| Q3 2018 | $1,274,000 | +129.5% | 22,263 | +94.7% | 0.07% | +111.4% |
| Q2 2018 | $555,000 | +2821.1% | 11,437 | +2187.4% | 0.04% | +1066.7% |
| Q1 2015 | $19,000 | -44.1% | 500 | -50.0% | 0.00% | -25.0% |
| Q2 2014 | $34,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |